Clinical Trial Update: Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)

View source ↗

Summary

The document summarizes a completed Phase III trial evaluating ocrelizumab's impact on functional impairment in multiple sclerosis patients, using multimodal ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Multiple Sclerosis | Status: COMPLETED